Diagnostic yield of next‐generation sequencing in fetuses with isolated increased nuchal translucency: systematic review and meta‐analysis
- 26 July 2021
- journal article
- review article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 59 (1) , 26-32
Abstract
Objective: To determine the diagnostic yield of exome or genome sequencing (ES/GS) over chromosomal microarray analysis (CMA) in fetuses with increased nuchal translucency (NT) and no concomitant anomalies.Methods: This systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta‐Analyses criteria. PubMed, Scopus and Web of Science were searched for studies describing ES/GS in fetuses with isolated increased NT. Inclusion criteria were: (1) study written in English; (2) more than two fetuses with increased NT > 99th percentile and no concomitant anomalies; and (3) a negative CMA result considered as the reference standard. Only positive variants identified on ES/GS that were classified as likely pathogenic or pathogenic and determined to be causative of the fetal phenotype were considered. Risk was assessed as the pooled effect size by single‐proportion analysis using random‐effects modeling (weighted by inverse of variance).Results: Eleven studies reporting on the diagnostic yield of ES/GS in fetuses with isolated increased NT > 99th percentile were identified and included 309 cases. All studies were high quality according to Standards for Reporting of Diagnostic Accuracy. Overall, a pathogenic or likely pathogenic variant was identified on ES/GS in 15 fetuses, resulting in a pooled incremental yield of 4% (95% CI, 2–6%). Six (40%) of these fetuses had NT of 5 mm or more. The observed inheritance pattern was autosomal dominant in 12 cases, including four fetuses with Noonan syndrome, autosomal recessive in two cases and X‐linked in one case.Conclusions: There is a 4% incremental diagnostic yield of ES/GS over CMA in fetuses with increased NT > 99th percentile without a concomitant anomaly. It is unclear whether a NT cut‐off higher than 3.5 mm may be more useful in case selection for ES/GS. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.Keywords
This publication has 26 references indexed in Scilit:
- Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta‐analysisUltrasound in Obstetrics & Gynecology, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Metaprop: a Stata command to perform meta-analysis of binomial dataArchives of Public Health, 2014
- Use of fetal nuchal translucency in the first trimester to predict single-gene disordersPrenatal Diagnosis, 2011
- Empirical evaluation showed that the Copas selection model provided a useful summary in 80% of meta-analysesJournal of Clinical Epidemiology, 2009
- Fixed‐Effect Versus Random‐Effects Models2009
- Combining fetal nuchal fold thickness with second‐trimester biochemistry to screen for trisomy 21Ultrasound in Obstetrics & Gynecology, 2007
- Increased nuchal translucency with normal karyotypeAmerican Journal of Obstetrics and Gynecology, 2005
- Meta-analysis, funnel plots and sensitivity analysisBiostatistics, 2000
- Bias in meta-analysis detected by a simple, graphicalBMJ, 1998